Avid Bioservices Inc (CDMO)

[masshysteria]

Thanks for posting cj.

Seems like the talk circuit for 1Q 2016 will include a set of messages Peregrine is looking to repeat and build some awareness in the appropriate circles.

The previous message you sent related to Jan 2016 meeting, and this one, talk to 'Recent Translational Data'. This will take information into the human realm and interpret what is seen through cellular and tumor micro-environment analysis that effect efficacy and health outcomes that would likely be visible months or years down the line through patient dosing/use of the drug combinations.

If anyone's looking for more MSK collaboration examples - read 'MSK collaboration' enabling and driving some of Peregrine's engagement in this conference and data to be shared. Peregrine of yesteryear would not have the horsepower and wherewithal to carry out this type of work and come to definitive and timely conclusions to be able to present it in this format and message implication (i.e. we (Peregrine) are telling you (potential collaboration partners) that there is a better way to get outcomes for Oncology patients than what you are currently considering).

It's all interpretive on my part but I feel pretty strongly about the picture that continues to shape up and the three dimensional puzzle that makes it up.

Best,

MH